Science Explorer Interactive view Map
Company · Tokyo · Japan

GlaxoSmithKline (Japan)

jp.gsk.comROR OpenAlex
World rank, all time
#30,384
of 42,892
Rank in Japan
#1,242
of 2,112
Research works
172
▼ 29% vs 2013–17
Citations
4.5k
26.3 per fractional work
Top-10% rate
15.0%
record average 16.5%
Open access
47%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.29× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.33× its world share, 0 worksImmunology and Micro…Neuroscience: 0.15× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.77× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.16× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringMathematics: 1.24× its world share, 0 worksMathematicsPhysics and Astronomy: 0.64× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.68× its world share, 1 worksHealth ProfessionsMedicine: 3.78× its world share, 10 worksMedicineVeterinary: 1.33× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.64× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.15× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.8×. Every wedge is a field page.

Who are the top researchers at GlaxoSmithKline (Japan)?

Ranked on the composite score, Akihiro Kobayashi lead among researchers whose main affiliation is GlaxoSmithKline (Japan).

  1. 1 Akihiro Kobayashi Japan · #1,017,662 worldwide 20 citations · 21 works
All ranked researchers at GlaxoSmithKline (Japan)

Which keywords describe research at GlaxoSmithKline (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Inflammation, Asthma, Diagnosis, Genetics, Immune Response and Global Burden.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology28▲ 4.1×47 topics
  2. Treatment20▲ 8.8×19 topics
  3. Inflammation18▲ 4.5×43 topics
  4. Diagnosis12▲ 6.7×17 topics
  5. Asthma12▲ 53×3 topics
  6. Genetics11▲ 8.2×6 topics
  7. Immune Response10▲ 9.8×16 topics
  8. Global Burden10▲ 11×9 topics
  9. Allergic Diseases10▲ 72×1 topic
  10. Eosinophils10▲ 72×1 topic
  11. Immunology10▲ 48×2 topics
  12. Management9▲ 6.5×10 topics
  13. Quality of Life7▲ 3.1×16 topics
  14. Respiratory6▲ 37×2 topics
  15. Antiretroviral Therapy6▲ 15×5 topics
  16. Cardiovascular Disease6▲ 2.9×19 topics
  17. COPD6▲ 51×1 topic
  18. spirometry6▲ 51×1 topic
  19. Vaccine5▲ 7.5×9 topics
  20. Genetic Variation5▲ 9.4×6 topics
  21. Antiviral Therapy5▲ 19×3 topics
  22. Liver Disease4▲ 19×2 topics
  23. Adverse Effects4▲ 30×2 topics
  24. Drug Resistance4▲ 7.8×3 topics
  25. Medicinal Chemistry4▲ 6.1×5 topics
  26. Hepatotoxicity4▲ 29×2 topics
  27. Heart Failure4▲ 4.6×9 topics
  28. Inhaler Devices4▲ 67×1 topic
  29. Pulmonary Drug Delivery4▲ 67×1 topic
  30. Treatment Guidelines3▲ 9.4×5 topics
  31. HIV Infection3▲ 15×2 topics
  32. Fibrosis3▲ 8.7×6 topics
  33. Hepatocellular Carcinoma3▲ 7.8×3 topics
  34. Integrase Inhibitors3▲ 41×1 topic
  35. Nucleoside Analogues3▲ 41×1 topic
  36. Chronic Cough3▲ 53×1 topic
  37. Cough Reflex Sensitivity3▲ 53×1 topic
  38. Monoclonal Antibodies3▲ 11×3 topics
  39. Nuclear Receptors3▲ 8.4×4 topics
  40. HIV2▲ 12×3 topics

Which research topics does GlaxoSmithKline (Japan) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, COVID-19 Clinical Research Studies, Respiratory viral infections research and SARS-CoV-2 and COVID-19 Research.

Asthma and respiratory d…1Asthma and respiratory diseases: 1 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksRespiratory viral infections research: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksDysphagia Assessment and Management: 0 fractional worksEosinophilic Esophagitis: 0 fractional worksMultiple Myeloma Researc…0Multiple Myeloma Research and Treatments: 0 fractional worksBotulinum Toxin and Related Neurological Disorders: 0 fractional worksVoice and Speech Disorders: 0 fractional worksDrug-Induced Hepatotoxic…0Drug-Induced Hepatotoxicity and Protection: 0 fractional works
PhysiologyInfectious DiseasesEpidemiologySpeech and Hearing4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 1 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  3. 3 Respiratory viral infections research Epidemiology 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 Dysphagia Assessment and Management Speech and Hearing 0 works
  6. 6 Eosinophilic Esophagitis Surgery 0 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 0 works
  8. 8 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
  9. 9 Voice and Speech Disorders Physiology 0 works
  10. 10 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 28% of research is openly available.

with international co-authors51.0%domestic only49.0%

World: 19% is written across borders.

How has GlaxoSmithKline (Japan)'s research output changed?

Output in 2018–2022 was 29% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.